Brightsurf Science News & Current Events

September 30, 2012
Breast cancer recurrence defined by hormone receptor status
Human epidermal growth factor positive breast cancers are often treated with the same therapy regardless of hormone receptor status.

Blocking key protein could halt age-related decline in immune system, Stanford study finds
The older we get, the weaker our immune systems tend to become, leaving us vulnerable to infectious diseases and cancer and eroding our ability to benefit from vaccination.

New insights on control of pituitary hormone outside of brain has implications for breast cancer
Recently, researchers have found that prolactin is also produced by some tissues outside the brain, however little is known about the functions of extra-pituitary prolactin or how its production is regulated in these tissues.

Researchers discover gene that causes deafness
Researchers at the University of Cincinnatiand Cincinnati Children's Hospital Medical Center have found a new genetic mutation responsible for deafness and hearing loss associated with Usher syndrome type 1.

Feature sensitive re-sampling of point set surfaces with Gaussian spheres
Feature sensitive re-sampling of point set surfaces is an important and challenging task in many computer graphics and geometric modeling applications.

Researchers discover key mechanism for controlling the body's inflammatory response
Researchers at Queen Mary, University of London have discovered how a key molecule controls the body's inflammatory responses.

Fish getting smaller as the oceans warm: UBC research
Changes in ocean and climate systems could lead to smaller fish, according to a new study led by fisheries scientists at the University of British Columbia.

New weapons in the fight against cancer
Several new first-in-man studies for drugs targeted against a range of cancers were released at the ESMO 2012 Congress of the European Society for Medical Oncology in Vienna.

Myths and misunderstandings hamper efforts to prevent cancer
New insights on the global fight to prevent cancers were presented during the ESMO 2012 Congress of the European Society for Medical Oncology in Vienna.

Are too few women being offered breast-conserving treatment?
Two new studies presented at the ESMO 2012 Congress in Vienna, Austria show how improvements in breast cancer treatments are making it possible for more women to conserve their breasts following therapy, but raise concerns about whether enough women are being offered these approaches.

A mysterious seed fern, Lepidopteris, discovered from the Upper Permian of China
A mysterious seed fern, Lepidopteris, with its entire epidermal structure of subepidermal swellings, was recently discovered from the Upper Permian of Shanxi, China.

Common RNA pathway found in ALS and dementia
Two proteins previously found to contribute to ALS, also known as Lou Gehrig's disease, have divergent roles.

The genetics of white finger disease
Vibration-induced white finger disease is caused by continued use of vibrating hand held machinery, and affects tens of thousands of people.

Climate change could cripple southwestern forests
Combine the tree-ring growth record with historical information, climate records, and computer-model projections of future climate trends, and you get a grim picture for the future of trees in the southwestern United States, according to a new study to be published in Nature Climate Change.

Scientists find missing link between players in the epigenetic code
New research from the University of North Carolina School of Medicine has established a new link between two fundamental epigenetic tags -- H3 lysine 9 methylation and DNA methylation -- in humans.

New pathogen epidemic identified in sub-Saharan Africa
Researchers have found that the spread of a dangerous bacteria that can be fatal in up to 45 percent of people infected in sub-Sahara Africa may have been instigated by the emergence and spread of HIV in Africa.

Phase III trial shows crizotinib superior to single-agent chemotherapy for ALK-positive lung cancer
The results of a new phase III trial show that crizotinib, a targeted therapy, is a more effective treatment than standard chemotherapy for patients with advanced, ALK-positive lung cancer, researchers said at the ESMO 2012 Congress of the European Society for Medical Oncology in Vienna. is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to